Consolidated net profit increased to AED 5.4 billion, reflecting a 129.9 per cent increase year-on-year growth ...

Discover how Brown & Brown, Inc. achieved 11.6% revenue growth in Q1 2025 through strategic acquisitions, organic growth, and expense management.

Equity amounted to ISK 42,421 million, and the equity ratio was 36.8% at the end of Q1 2025, compared to 37.9% at year-end ...

Discover Astec Industries' impressive Q1 2025 earnings with 86% EBITDA growth, TerraSource acquisition insights, and strategic moves to combat ...

General Motors posted strong financial results for its first quarter Tuesday, but says it will reassess its expectations for ...

Wall Street is sifting through a rush of earnings reports and economic data, amid hopes for auto tariff relief.

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

Q1 2025 Management View CEO Kevin Wheeler highlighted a significant leadership change, with Stephen Shafer assuming the role ...

Financial news including quarterlies, annuals, and regulatory actions about biometrics and digital identity firm Idex ...

Ionis Pharmaceuticals (NASDAQ:IONS) is scheduled to announce Q1 earnings results on Wednesday, April 30th, before market open. The consensus EPS Estimate is -$1.03 and the consensus Revenue Estimate ...